We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Linagliptin Nitroso Impurity 7
Linagliptin Nitroso Impurity 7
CAT No SRC-N0141176
CAS No NA
Mol.F. C16H12BrN7O3
Mol.Wt. 430.2
INV STATUS CUSTOM SYNTHESIS
Linagliptin Nitroso Impurity 8
Linagliptin Nitroso Impurity 8
CAT No SRC-N0141177
CAS No NA
Mol.F. C16H13N7O3
Mol.Wt. 351.3
INV STATUS CUSTOM SYNTHESIS
Linagliptin Nitroso Impurity 9 | N-Nitroso-8-Bromo-3-Methyl Xanthine
Linagliptin Nitroso Impurity 9  |  N-Nitroso-8-Bromo-3-Methyl Xanthine
CAT No SRC-N0141178
CAS No NA
Mol.F. C6H4BrN5O3
Mol.Wt. 274.0
INV STATUS CUSTOM SYNTHESIS
N-Nitroso N-Desmethyl Linagliptin
N-Nitroso N-Desmethyl Linagliptin
CAT No SRC-N0141179
CAS No NA
Mol.F. C24H25N9O3
Mol.Wt. 487.5
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Linagliptin Related Compound B
N-Nitroso Linagliptin Related Compound B
CAT No SRC-N0141180
CAS No NA
Mol.F. C30H35N9O5
Mol.Wt. 601.7
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Bupivacaine EP Impurity E
N-Nitroso Bupivacaine EP Impurity E
CAT No SRC-N0141181
CAS No NA
Mol.F. C18H29N3O2
Mol.Wt. 319.4
INV STATUS UNDER SYNTHESIS
N-Nitroso Aniline
N-Nitroso Aniline
CAT No SRC-N0141182
CAS No 36966-84-4
Mol.F. C6H6N2O
Mol.Wt. 122.1
INV STATUS UNDER SYNTHESIS
Rotigotine Nitroso Impurity 1
Rotigotine Nitroso Impurity 1
CAT No SRC-N0141183
CAS No NA
Mol.F. C9H14N2OS
Mol.Wt. 198.3
INV STATUS CUSTOM SYNTHESIS
1-Nitroso-1,2,4-Triazole
1-Nitroso-1,2,4-Triazole
CAT No SRC-N0141184
CAS No 70890-80-1
Mol.F. C2H2N4O2
Mol.Wt. 114.1
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Clonazepam
N-Nitroso Clonazepam
CAT No SRC-N0141185
CAS No NA
Mol.F. C15H9ClN4O4
Mol.Wt. 344.7
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.